Notification according to Chapter 2, Section 10 of the Finnish Securities Market Act
(Thomson Reuters ONE) -
BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 3 February 2011 at 5.30 p.m.
Notification according to Chapter 2, Section 10 of the Finnish Securities Market
Act
Biotie Therapies Corp. ("Company" or "Biotie") has gained knowledge of the
notifications regarding changes in holdings in accordance with Chapter 2,
Section 9 of the Finnish Securities Markets Act, described below.
The notifications received by the Company concern the changes in holdings of
Suomen itsenäisyyden juhlarahasto ("Sitra").
The mentioned change in holdings is related to the Combination Agreement entered
into on 10 January 2011 among the Company, Synosia Therapeutics Holding AG
("Synosia") as well as Synosia's shareholders and warrant holders, described in
more detail in a stock exchange release issued on 11 January 2011. As described
in detail in Biotie's stock exchange release issued on 2 February 2011, Biotie's
Extraordinary General Meeting has on 1 February 2011 passed resolutions
necessary for the completion of the transaction and the other prerequisites for
the completion of the transaction have been fulfilled, and the Company has
issued 161,448,371 shares to the shareholders and warrant holders of Synosia as
consideration for the entire issued share capital and outstanding warrants of
Synosia (the "Transaction"). In connection with the Transaction, the Company
issued 14,912,155 new shares to Synosia to be held in treasury and used to
satisfy future potential exercise of Synosia's options. The new shares have been
registered on 3 February 2011.
As a consequence of the Transaction Sitra's holding of shares and votes in the
Company decreased below 5 % as follows:
Name Number of Number of Number of Share of Share of
shares voting shares and share voting
before rights voting capital rights after
Transaction before rights after after Transaction
Transaction Transaction Transaction (%)
(%)
Suomen 13,585,350 13,585,350 13,585,350 3.86 4.21
itsenäisyyden
juhlarahasto
The number of voting rights and percentages presented above are calculated based
on number of shares and voting rights obtained upon completion of the
Transaction taking into account the treasury shares held by the Company on the
date of the notification.
On the date hereof, the registered number of shares in Biotie Therapies Corp. is
352,364,457. Of these shares 29,659,239 are held by the Company or its group
companies and the number of outstanding registered shares and voting rights
attached to such shares amounts thus to 322,705,218.
Turku, 3 February 2011
Biotie Therapies Corp.
Timo Veromaa
President and CEO
For further information, please contact:
Virve Nurmi, Biotie Therapies Corp.
tel. +358 2 274 8900
e-mail:virve.nurmi(at)biotie.com
DISTRIBUTION
NASDAQ OMX Helsinki Ltd
Main Media
www.biotie.com
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Biotie Therapies Oyj via Thomson Reuters ONE
[HUG#1485220]
Unternehmensinformation / Kurzprofil:
Datum: 03.02.2011 - 16:30 Uhr
Sprache: Deutsch
News-ID 51057
Anzahl Zeichen: 4047
contact information:
Town:
Turku
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 141 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Notification according to Chapter 2, Section 10 of the Finnish Securities Market Act"
steht unter der journalistisch-redaktionellen Verantwortung von
Biotie Therapies Oyj (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
